Joseph Yanchik III resigned as president, CEO and director of Aileron Therapeutics Inc.
The clinical-stage biopharmaceutical company named John Longenecker as interim CEO. Longenecker is the founder and president of JPL Biotech, a biopharma/pharmaceutical consulting company.
